PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Allergy and Clinical Immunology Section, Biotechnology and Moleculer Biology Unit, Academia Sinica, Genomics Research Center, Taipei, Taiwan.\', \'Division of Allergy and Immunology, Department of Internal Medicine, Health Science University Antalya Education and Research Hospital, Antalya, Turkey.\', \'Medicine Faculty, Department of Infectious Disease and Clinical Microbiology, Akdeniz University, Antalya, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/08923973.2020.1818770
?:hasPublicationType
?:journal
  • Immunopharmacology and immunotoxicology
is ?:pmid of
?:pmid
?:pmid
  • 32883116
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.711
?:rankingScore_hIndex
  • 41
?:title
  • Future perspective: biologic agents in patients with severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32883116>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32883116>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all